| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $39.55M | $57.80M | $176.23M | $111.30M | $110.70M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $160.79M | $161.77M | $450.24M | $312.58M | $294.04M |
| R&D | $112.67M | $111.52M | $234.06M | $249.90M | $230.82M |
| SG&A | $34.89M | $44.73M | $61.17M | $62.68M | $63.22M |
| Operating Income | -$121.24M | -$103.97M | -$274.00M | -$201.28M | -$183.34M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$568.00K | -$167.00K | -$5.07M | $429.00K | $306.00K |
| Net Income | -$122.93M | -$97.94M | -$257.83M | -$192.28M | -$178.29M |
| EPS (basic) | -0.4400 | -0.4900 | -1.4800 | -1.2500 | -1.2300 |
| EPS (diluted) | -0.4400 | -0.4900 | -1.4800 | -1.2500 | -1.2300 |
| Shares (diluted) | $280.19M | $201.70M | $174.44M | $154.34M | $144.57M |